- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01162226
Computer-Based Balance Training for People With Parkinson's Disease
April 17, 2012 updated by: Glenna Dowling, University of California, San Francisco
"PD Wii: Computer-based Gait and Balance Training for Parkinson's Patients".
This study will be carried out to determine the effectiveness of in-home computer games played by a person with Parkinson's disease for 50 minutes 3 times a week on measures of standing and walking balance.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
62
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Francisco, California, United States, 94143-0610
- University of California, San Francisco
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- presence of bradykinesia along with at least one of the following: muscular rigidity, 4-6 Hz rest tremor, and postural instability (Gelb, Oliver, & Gilman, 1999; Hughes, Ben-Shlomo, Daniel, & Lees, 1992).
- Hoehn & Yahr disease Stage 1 (unilateral disease) to 3 (mild to moderate bilateral disease, physically independent) (Fahn and Elton, 1987).
Exclusion Criteria:
- history of strokes, repeated head injury, encephalitis, oculogyric crises, neuroleptic treatment, MPTP exposure, more than one affected relative, sustained remission, strictly unilateral features after 3 years, supranuclear gaze palsy, early severe autonomic involvement or dementia, Babinski sign, tumor, or a negative response to L-DOPA (Hughes et al., 1992).
- other neurologic, orthopedic or cardiac problems, cognitive impairment as evidenced by 5 or more errors on the Mini Mental State Examination (MMSE) (Folstein, Folstein, & McHugh, 1975)
- visual or hearing impairments serious enough to interfere with their ability to interact with the computer-based training program.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: training program
|
The intervention will be implemented via three 50-minute training sessions per week for 12 weeks.
The games will be played when the subject is receiving the maximum benefit from their anti-parkinsonian medications.
The control group and the intervention group will receive weekly telephone calls to inquire about medications and falls.
At baseline and end of the 12 weeks, in-home testing will determine stride length and speed; standing balance eyes open and closed on flat and foam surface.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
gait
Time Frame: 3 months
|
Gait velocity and stride length will be measured with WriteStep Gait and Mobility pads (Abilitations).
For the gait analysis, subjects will walk along a 10 foot walkway (gait velocity) that will record the footprint patterns from which we will evaluate the time it takes to walk the distance of the walkway and the average stride length.
Each subject will walk according to standard protocol of 1 trial at his/her self-selected speed to enable an accurate representation of usual gait.
|
3 months
|
|
balance
Time Frame: 3 months
|
Balance will be objectively measured using the modified Clinical Test for Sensory Interaction and Balance (CTSIB) (Shumway-Cook & Horak, 1986).
There are 2 conditions with a stable platform (eyes open and eyes closed) and 2 conditions on a less stable foam surface, (eyes open and eyes closed).
Following the standardized protocol, subjects will be tested 3 times in each condition on the stable surface and 3 times in each unstable condition for up to thirty seconds each.
The number of seconds standing will be summed across all 12 trials for a range of 0-360 seconds.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
falls
Time Frame: weeks 1-12
|
Weekly phone inquiry will quantify number of falls if any, during the past week.
|
weeks 1-12
|
|
overall functional status
Time Frame: 3 months
|
Functional status will be assessed by the Unified Parkinson's Disease Rating Scale (UPDRS, Parts 2 & 3) (Fahn, Elton, & Members of the UPDRS Committee, 1987).
Part 2 is a quantitative 5-point scale that measures the subjects' perception of their functional status.
Part 3 is also a 5-point scale in which a clinician evaluates actual functional status by physical exam.
The scores on each item in Parts 2 & 3 are summed to yield a total score.
|
3 months
|
|
subjective balance
Time Frame: 3 months
|
Subjective balance will be assessed by the Activities-specific Balance Confidence (ABC) Scale (Powell & Myers, 1995).
This instrument assesses subjective balance/fear of falling by asking subjects to rate the degree of confidence that they have for completing 16 activities of daily living without falling.
Ratings are summed and then divided by 16 (or the number of items completed) to yield a total ABC score.
|
3 months
|
|
balance
Time Frame: 3 months
|
Timed up and go test (TUG) will be a secondary measure of balance.
Subjects are seated in a straight back chair with arms.
On the command "GO" the stop watch is started.
Subject stands, walks toward a visible object on the floor positioned 8 feet from chair, walk around the object, return to chair and sit down.
After a practice, 3 TUG will be performed.
Times will be documented in seconds.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Glenna A Dowling, PhD, University of CA San Francisco
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Powell LE, Myers AM. The Activities-specific Balance Confidence (ABC) Scale. J Gerontol A Biol Sci Med Sci. 1995 Jan;50A(1):M28-34. doi: 10.1093/gerona/50a.1.m28.
- Fahn, S., Elton, R., & Members, U. C. (1987). Unified Parkinson's disease rating scale. In S. Fahn, C. D. Mardsen, M. Goldstein & D. Calne (Eds.), Recent Developments in Parkinson's Disease (pp. 153-163). New Jersey: Macmillan Healthcare Information. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975).
- Folstein MF, Folstein SE, McHugh PR.
- Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999 Jan;56(1):33-9. doi: 10.1001/archneur.56.1.33.
- Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 1992 Jun;42(6):1142-6. doi: 10.1212/wnl.42.6.1142. Erratum In: Neurology 1992 Jul;42(7):1436.
- Shumway-Cook A, Horak FB. Assessing the influence of sensory interaction of balance. Suggestion from the field. Phys Ther. 1986 Oct;66(10):1548-50. doi: 10.1093/ptj/66.10.1548. No abstract available.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
July 1, 2011
Study Completion (Actual)
July 1, 2011
Study Registration Dates
First Submitted
June 24, 2010
First Submitted That Met QC Criteria
July 12, 2010
First Posted (Estimate)
July 14, 2010
Study Record Updates
Last Update Posted (Estimate)
April 19, 2012
Last Update Submitted That Met QC Criteria
April 17, 2012
Last Verified
April 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2R42NS061502-02 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease
-
EicOsis Human Health Inc.University of California, Davis; Michael J. Fox Foundation for Parkinson's...RecruitingParkinson's Disease (PD)United States
-
University of Kansas Medical CenterNot yet recruitingParkinson's Disease (PD)United States
-
AbbVieRecruiting
-
University Hospital Schleswig-HolsteinUniversity of Kiel; University of Cologne; University Hospital, Bonn; Philipps...Not yet recruitingParkinson's Disease (PD)
-
InvicroMerck Sharp & Dohme LLCRecruitingParkinson's Disease | Parkinson's Disease (PD) | Parkinson's Disease (Disorder)United States
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationUnknownHealthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 MutationFrance
-
Guangzhou Henovcom Bioscience Co. Ltd.Frontage Clinical Services, Inc.Active, not recruitingParkinson's Disease (PD)United States
-
Universitätsklinikum Hamburg-EppendorfUniversity of TwenteRecruitingParkinson's Disease | Deep Brain StimulationGermany
-
Mission TherapeuticsMichael J. Fox Foundation for Parkinson's Research; Parkinson's UKRecruitingParkinson's Disease (PD) | Early Stage Parkinson's Disease | Mild to Moderate Parkinson's DiseaseUnited Kingdom
Clinical Trials on gait and balance training program
-
Forschungszentrum JuelichHeinrich-Heine University, DuesseldorfRecruitingParkinson Disease | AtaxiaGermany
-
Princess Nourah Bint Abdulrahman UniversityActive, not recruitingChildren With Acquired Brain InjurySaudi Arabia
-
Qassim UniversityCairo UniversityCompletedBurn | Pediatric Burns | Burn RehabilitationEgypt
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
University Hospital, GhentUniversity GhentRecruitingStroke | Traumatic Brain Injury | Spinal Cord InjuriesBelgium
-
Abant Izzet Baysal UniversityRecruitingStroke | Balance Impairment | Gait ImpairmentTurkey (Türkiye)
-
King Edward Medical UniversityNot yet recruitingChemotherapy Induced Peripheral Neuropathy (CIPN)Pakistan
-
Medical College of WisconsinMarquette University; Froedtert Hospital; Advancing a Healthier Wisconsin EndowmentNot yet recruitingDegenerative Cervical MyelopathyUnited States
-
Medical University of South CarolinaBrooks RehabilitationCompleted
-
National University Health System, SingaporeNational University Hospital, Singapore; National Medical Research Council...CompletedDiabetic Neuropathies | Peripheral Nervous System DiseasesSingapore